The escalating global prevalence of antibiotic-resistant Helicobacter pylori strains has undermined conventional eradication therapies, heightening the burden of associated conditions such as gastritis, peptic ulcers and gastric malignancies. Emerging non-antibiotic alternatives, including natural and synthetic compounds, probiotics and vaccine candidates, offer potential solutions to combat these infections effectively. Natural and synthetic compounds provide promising anti-H. pylori effects, primarily through bacterial membrane disruption, urease inhibition, virulence gene suppression and biofilm prevention. in vitro and in vivo studies support the robust activity of natural agents, while synthetic counterparts demonstrate potent bactericidal and anti-adherence capabilities, though rigorous clinical validation is still required. Probiotic strains enhance eradication rates when combined with antibiotics, reduce treatment-related adverse effects, modulate gut microbiota and attenuate gastric inflammation and carcinogenesis. Vaccine development encompasses whole-cell, subunit and DNA platforms targeting key virulence factors, showing immunogenicity and protective efficacy in preclinical models, yet is limited by variable clinical translation and insufficient large-scale trials. Despite promising advancements, challenges persist, including inconsistent efficacy and a need for more rigorous human studies. Future efforts should emphasize combinatorial therapies, refined delivery systems, and thorough safety evaluations to integrate these strategies into clinical practice, fostering sustainable management of H. pylori in a post-antibiotic era.

The term ‘autophagy’ literally translates to ‘self-eating’ and alterations to autophagy have been identified as one of the several molecular changes that occur with aging in a variety of species. Autophagy and aging, have a complicated and multifaceted relationship that has recently come to light thanks to breakthroughs in our understanding of the various substrates of autophagy on tissue homoeostasis. Several studies have been conducted to reveal the relationship between autophagy and age-related diseases. The present review looks at a few new aspects of autophagy and speculates on how they might be connected to both aging and the onset and progression of disease. Additionally, we go over the most recent preclinical data supporting the use of autophagy modulators as age-related illnesses including cancer, cardiovascular and neurodegenerative diseases, and metabolic dysfunction. It is crucial to discover important targets in the autophagy pathway in order to create innovative therapies that effectively target autophagy. Natural products have pharmacological properties that can be therapeutically advantageous for the treatment of several diseases and they also serve as valuable sources of inspiration for the development of possible new small-molecule drugs. Indeed, recent scientific studies have shown that several natural products including alkaloids, terpenoids, steroids, and phenolics, have the ability to alter a number of important autophagic signalling pathways and exert therapeutic effects, thus, a wide range of potential targets in various stages of autophagy have been discovered. In this review, we summarised the naturally occurring active compounds that may control the autophagic signalling pathways.

Plants that release molecules affecting other plants are a source of potential bioherbicides. Silver wattle (Acacia dealbata Link), considered invasive worldwide, was found to be phytotoxic to various other plant species. Combining the search for alternative bioherbicides while reducing the spread of this invader by preventing seed formation is a good potential strategy to solve both agricultural and environmental problems. This study aimed to identify nonvolatile compounds from A. dealbata flowers and explore their phytotoxicity on the germination process and seedling and plant growth of lettuce (Lactuca sativa L.), wheat (Triticum aestivum L.), and rigid ryegrass (Lolium rigidum Gaudin). We identified methyl cinnamate and methyl anisate as potential phytotoxins in the extracts, but we used pure commercial molecules to conduct bioassays. Methyl cinnamate showed higher phytotoxicity than methyl anisate and was selected for further bioassays. Methyl cinnamate reduced guaiacol peroxidase activity by 57% and 85% in L. rigidum and lettuce, respectively, and α-amylase by 6% in L. rigidum. This compound also inhibited early stem and radicle growth of dicotyledonous lettuce (60% and 89%, respectively) and monocotyledonous L. rigidum (76% and 87%, respectively), both species having small seeds. However, wheat with a larger seed size was not affected by the phytotoxin. The results obtained indicate a potential bioherbicidal effect for methyl cinnamate, and its application might be useful in wheat crops infested by L. rigidum. We suggest that collecting A. dealbata flowers would prevent Acacia seed formation and thus play a role in invasive pest management, as well as serving as a source of potential herbicides to other species.